AI Task Time

Assess Whether a Skin Mole Is Cancerous via Visual Inspection and Patient History

“Assess whether a mole on a patient's skin is cancerous based on visual inspection and patient history”

Summary · Assess whether a skin mole is cancerous via visual inspection and patient history — a clinical diagnostic task requiring licensed medical judgment.

AI verdict · poor

This is a high-stakes medical diagnostic task requiring licensed clinical judgment, physical examination, dermoscopy, and potentially biopsy. AI image tools show research promise but are not FDA-approved standalone diagnostics, degrade with real-world photo quality, and cannot be used without mandatory clinician review. AI cannot legally or safely replace a dermatologist for this task today.

Teledermatology platforms (agency profile) reduce calendar wait time from weeks to hours for initial screening, though biopsy still requires in-person follow-up.

1.5 hrs

saved per week using AI

Worker comparison

01
Solo Individual
DIY on your own time, no contract, no schedule
Not safely doable; attempting self-diagnosis takes 15–60 minutes but is unreliable and dangerous $0 direct cost, but potentially very high cost of missed diagnosis A layperson using online guides or symptom checkers (ABCDE criteria) can do a surface-level self-check, but they lack the clinical training to reliably distinguish benign from malignant lesions. False reassurance is a serious risk. Dermoscopy tools and biopsy are not available. The output of this effort has very low diagnostic value and should not be acted upon without professional confirmation. high
02
Solo Expert
Hire a freelance specialist, day rate, scoped per job
10–20 minutes per patient encounter, including history and clinical assessment $150–$350 per office visit (dermatologist or GP with dermatology training), not including biopsy A trained dermatologist or experienced GP can apply dermoscopy, clinical judgment, and ABCDE criteria meaningfully. However, even experts have limits: visual-only diagnosis without biopsy carries real diagnostic uncertainty. Scheduling an appointment typically involves a wait of days to weeks. The expert's assessment may still recommend biopsy for confirmation, adding cost and time. Referral friction and insurance pre-authorization can create additional delays. high
03
Small Team
Coordinate 2 or 3 freelancers, handoffs and gaps
20–40 minutes including triage nurse intake, physician review, and documentation $200–$500 per encounter, depending on facility and whether biopsy is ordered A clinical team (nurse, dermatologist, possibly a pathologist on standby) provides more systematic care with better documentation and workflow. However, this setting still requires an in-person visit with all associated scheduling friction. Care coordination between team members can add latency. Biopsy pathology, if ordered, adds 5–10 business days for results. Billing complexity rises in multi-provider settings. high
04
Agency
Account-managed, billable hours, formal scope and SOW
Teledermatology service: 24–72 hours for asynchronous review; real-time consult 15–30 minutes $50–$150 for teledermatology consult; higher for in-person dermatology clinic visit plus any procedures Commercial teledermatology platforms (e.g., DermEngine, First Derm) can route submitted photos and history to board-certified dermatologists quickly. Quality depends heavily on photo quality — poor lighting or resolution degrades diagnostic accuracy significantly. These services typically disclaim that visual-only assessment is not a definitive diagnosis and cannot replace biopsy. Refund or dispute policies vary; escalation if the assessment is later found wrong is not straightforward. medium
05
Enterprise
RFP, procurement, multi-stakeholder approvals
Multi-step process: initial visit, possible biopsy, pathology review — spanning 1–4 weeks total $500–$2,000+ depending on biopsy, pathology, imaging, and insurance coverage; enterprise oncology workflows can be higher Hospital or health system oncology and dermatology departments offer the highest diagnostic accuracy through structured workflows: clinical review, dermoscopy, biopsy, histopathology, and multidisciplinary tumor board if needed. However, bureaucratic overhead is significant — prior authorizations, referral queues, EMR documentation, and insurance billing all extend wall-clock time substantially. The definitive answer often comes weeks after the initial concern is raised. Patient experience friction is high. high
AI
AI (Claude / Agent)
AI plus competent human review
AI image screening tool: near-instant analysis; human clinician review of AI output adds 5–15 minutes $0–$50 for AI-assisted screening tools; cannot replace a clinician visit and is not an approved standalone diagnostic AI dermatology tools (e.g., trained CNNs on dermoscopic images) have shown promising sensitivity for melanoma detection in research settings, but none are approved as standalone diagnostic devices by the FDA for clinical decision-making without clinician oversight. Key failure modes: performance degrades on low-quality smartphone photos; AI can miss rare lesion types; it cannot gather nuanced patient history or perform palpation. Any AI output must be reviewed and confirmed by a licensed clinician — AI cannot legally or ethically replace that judgment. Using AI here without mandatory human clinical review is unsafe and exposes operators to significant liability. The AI profile here assumes AI as a triage aid, not a replacement. high

This task is a poor fit for AI. See goodaitask.com to check what is worth handing to AI.

Check on Good AI Task

Time, visually

01 Solo Individual
Not safely doable; attempting self-diagnosis takes 15–60 minutes but is unreliable and dangerous
02 Solo Expert
10–20 minutes per patient encounter, including history and clinical assessment
03 Small Team
20–40 minutes including triage nurse intake, physician review, and documentation
04 Agency
Teledermatology service: 24–72 hours for asynchronous review; real-time consult 15–30 minutes
05 Enterprise
Multi-step process: initial visit, possible biopsy, pathology review — spanning 1–4 weeks total
AI AI (Claude / Agent)
AI image screening tool: near-instant analysis; human clinician review of AI output adds 5–15 minutes

Related tasks

Share or try another